Top Markets
#1 Siren Siren +30.45%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +26.06%
#3 OriginTrail OriginTrail +21.43%
#4 DogBull DogBull +14.01%
#5 MarsCoin MarsCoin +12.76%
#6 COTI COTI +9.75%
#7 Xphere Xphere +6.05%
#8 Concordium Concordium +6.00%
#9 PulseChain PulseChain +5.89%
#10 Pons Pons +5.77%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Cutia Therapeutics Cutia Therapeutics

Cutia Therapeutics

2487
Rank in Stocks #22318
Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a... Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a robust dermatology platform for addressing conditions affecting both the skin and scalp. Its comprehensive therapeutic scope encompasses various dermatological challenges, including medications for localized fat accumulation, advanced care for scalp disorders, treatments for a wide array of skin ailments, and topical pain management. Founded in 2019, the company's main headquarters are situated in Shanghai, China, complemented by additional offices located in Beijing, Wuxi, and Hong Kong.
Share Price
$0.24945615
Last synced: 2026-08-21
Market Cap
$90.64M
Change (1 day)
-10.14%
Change (1 year)
-79.61%
Country
CN
Trade Cutia Therapeutics (2487)

Category

Healthcare
Earnings for Cutia Therapeutics (2487)
Earnings in 2026 TTM: 0
According to Cutia Therapeutics latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cutia Therapeutics from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH